Realme Pad 2 offers several other improvements when compared to the previous generation. One of the most noticeable changes is in terms of the screen-to-body ratio, which has been increased from 82.5 ...

Becton, Dickinson and Company (BD) is set to initiate a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, aimed at measuring real-world outcomes for individuals with peripheral ...

AngioDynamics, Inc. ANGO recently launched the Auryon Atherectomy System, a newly developed path-breaking technology for the treatment of Peripheral Artery Disease (“PAD”), which includes Critical ...

Endologix has reported the 36-month outcomes of a study that evaluated its DETOUR System for treating complex peripheral arterial disease (PAD). The DETOUR 2 Study results were presented at the VIVA ...